Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Open Access
- 27 July 2024
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (11) , 4717-4737
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 213 references indexed in Scilit:
- Metal‐DNA Nanocomplexes Enhance Chemo‐dynamic Therapy by Inhibiting Autophagy‐Mediated ResistanceAngewandte Chemie International Edition, 2023
- Blocking Cholesterol Metabolism with Tumor‐Penetrable Nanovesicles to Improve Photodynamic Cancer ImmunotherapySmall Methods, 2022
- Supramolecular nanotherapeutics enable metabolic reprogramming of tumor‐associated macrophages to inhibit tumor growthJournal of Biomedical Materials Research Part A, 2022
- Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin SignalingPharmaceutical Research, 2021
- Acly promotes metabolic reprogramming and induction of IRF4 during early CD8+ T cell activationCytometry Part A, 2020
- The IKKβ‐USP30‐ACLY Axis Controls Lipogenesis and TumorigenesisHepatology, 2020
- Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate‐induced apoptosisMolecular Oncology, 2018
- Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer TherapyAngewandte Chemie International Edition, 2017
- Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate LyaseCurrent Atherosclerosis Reports, 2016
- ber den Stoffwechsel der CarcinomzelleThe Science of Nature, 1924